Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impacts of Dexmedetomidine as an Adjuvant for Femoral Nerve Block on Functional Recovery in Aged Patients After Total Knee Arthroplasty: a Randomized, Double-blinded, Controlled Trial

NCT04642651 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT04642651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04642651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impacts of Dexmedetomidine as an Adjuvant for Femoral Nerve Block on Functional Recovery in Aged Patients After Total Knee Arthroplasty: a Randomized, Double-blinded, Controlled Trial
Lead sponsor
Peking University First Hospital
Phase
Phase 4
Overall status
Completed
Start date
November 25, 2020
Completion date
February 25, 2022
Enrollment
170 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, elderly, femoral nerve block, functional outcome, total knee arthroplasty